WASHINGTON, July 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2020 on Thursday, July 23, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight Software delivers ready-made infrastructure to realize the full potential of whole-genome sequencing for rare genetic diseases. This new offering enables sample-to-report analysis for genetic disease... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) has selected seven early-stage companies to join the first global cohort of Illumina Accelerator, the company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. Three companies comprise the inaugural funding cycle of Illumina Accelerator Cambridge, UK and four companies will join as part of the 11th... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI Tech Co., Ltd., Complete Genomics Inc., BGI Americas Corp., and MGI Americas Inc. The preliminary injunction was granted in two patent infringement lawsuits that Illumina... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end workflow extends the options... Read more
Researchers use scanning electron microscopy (SEM) to characterize a lightweight, flexible material with high performance shielding capabilities From wearable fitness trackers, such as smartwatches, to wearable healthcare devices, such as ECG and blood pressure monitors, there is a rising demand for increasingly advanced wearable devices. Devices such as these are packed with highly integrated circuits,... Read more
Lactoscope™ FT-B instrument provides accurate, cloud-connected testing and results in under 45 seconds WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the LactoScope™ FT-B instrument, which delivers quick and accurate full spectrum component testing and adulterant screening for liquid dairy products such as whey, raw and skim milk, shelf... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our DNA, and together with the Illumina Corporate Foundation, we have committed more than $10M to support the communities where we live... Read more
Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering WASHINGTON, May 8, 2020 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher”) announced today that it has priced concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,550,000 shares of 5.00% Series B Mandatory Convertible Preferred... Read more
Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock WASHINGTON, May 7, 2020 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher”) announced today that it has commenced concurrent offerings of $1.25 billion of shares of common stock and $1.25 billion of shares of Series B Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings).... Read more